首页 » 论文 » 医药、卫生 » 正文
江苏医药业上市公司可持续增长的实证研究
 
文档类型 doc 更新日期 2013-12-03 10:04
文件大小 0.1M 浏览次数 320
下载次数 0 论文下载 下载
 
详细介绍
 

江苏医药业上市公司可持续增长的实证研究*


 

[摘要] 罗伯· 希金斯的可持续增长模型认为,持续增率是指在不需耗尽财务资的情况下公司销售所能增长的最本文以可持续增长模型作为理论基础,对江苏医药业上市公司可持续增长情况了进行实证研究。研究表明:江苏医药业上市公司的实际增长率超过可持续增长率,并且呈现逐年上升的趋势,这种快速增长会加速企业财务资源的消耗。进一步从财务角度分析了可持续增长的动力因素,并提出了相应的对策建议。

[关键词]可持续增长模型;医药业上市公司; 动力因素;权益资本

Empirical study on the Sustainable Growth of listed companies in Pharmaceutical Industry in Jiangsu province


[Abstract]  According to the sustainable growth model by Robert Higginsthe Sustainable Growth Rate is that, under the condition without using up the finance resources, maximal-ratio of company sales growth that can be achieved. This paper based on the theory of the Sustainable Growth Model (SGM) makes an empirical study on the Sustainable Growth on listed companies in pharmaceutical industry in Jiangsu province.The study shows that the real growth rate of listed companies in pharmaceutical industry in Jiangsu province exceeds the sustainable growth rate, which trends to rising year by year, and that the fast growth will speed up consumption on company finance resources. This paper also makes a further analysis on sustainable growth power factors from a financial perspective and forwards relevant countermeasures and suggestions

[key words]  Sustainable Growth Model (SGM); listed companies inPharmaceuticalIndustry;

power factors; equity capital.

 

 



*系江苏省高校哲学社会科学基金项目“嵌入全球价值链的江苏医药产业集群可持续发展问题的研究” 07SJD790029、江苏省哲学社会基金项目“江苏医药制造产业提升主导产业研究”08EYB011阶段成果。

 


您还没登录,登录后查看详情
 

 

 

 

免费注册会员以后,您可以享受以下权利

 

发布供求信息 推广企业产品


发布供求信息 推广企业产品

 


 
相关评论
 
分类浏览
 
展开
 
 
 

京ICP备2022013646号-3

(c)2008-2013 学术规划网 All Rights Reserved

 

免责声明:本站仅限于整理分享学术资源信息及投稿咨询参考;如需直投稿件请联系杂志社;另涉及版权问题,请及时告知!